Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 8 | 2022 | 462 | 3.480 |
Why?
|
| Analgesia | 2 | 2022 | 57 | 1.630 |
Why?
|
| Myocardial Infarction | 3 | 2018 | 376 | 1.330 |
Why?
|
| Hypotension | 2 | 2017 | 70 | 1.010 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2024 | 139 | 0.990 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 350 | 0.930 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2022 | 237 | 0.920 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2022 | 9 | 0.890 |
Why?
|
| Coronary Artery Bypass | 3 | 2022 | 228 | 0.890 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 134 | 0.840 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 109 | 0.820 |
Why?
|
| Morphine | 1 | 2021 | 130 | 0.760 |
Why?
|
| Postoperative Complications | 6 | 2022 | 2207 | 0.750 |
Why?
|
| Robotic Surgical Procedures | 2 | 2022 | 267 | 0.740 |
Why?
|
| Kidney Diseases | 2 | 2022 | 418 | 0.730 |
Why?
|
| Monitoring, Intraoperative | 2 | 2018 | 109 | 0.730 |
Why?
|
| Medicine | 1 | 2021 | 89 | 0.730 |
Why?
|
| Echocardiography, Transesophageal | 5 | 2018 | 344 | 0.720 |
Why?
|
| Hospital Rapid Response Team | 1 | 2019 | 27 | 0.700 |
Why?
|
| Marriage | 1 | 2019 | 26 | 0.680 |
Why?
|
| Mitral Valve | 4 | 2021 | 248 | 0.670 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 1 | 2019 | 35 | 0.650 |
Why?
|
| Wireless Technology | 1 | 2018 | 16 | 0.640 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 131 | 0.620 |
Why?
|
| Heart-Assist Devices | 4 | 2022 | 731 | 0.620 |
Why?
|
| Myocardium | 2 | 2022 | 529 | 0.620 |
Why?
|
| Cystectomy | 1 | 2018 | 102 | 0.610 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2018 | 71 | 0.610 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 413 | 0.600 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2017 | 21 | 0.590 |
Why?
|
| Mitochondria | 1 | 2019 | 535 | 0.540 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 295 | 0.540 |
Why?
|
| Humans | 33 | 2024 | 86643 | 0.530 |
Why?
|
| Lung Transplantation | 1 | 2017 | 175 | 0.510 |
Why?
|
| Liver Transplantation | 1 | 2022 | 1268 | 0.500 |
Why?
|
| Endoscopy | 2 | 2022 | 332 | 0.500 |
Why?
|
| Aortic Valve | 4 | 2022 | 222 | 0.490 |
Why?
|
| Angiotensins | 1 | 2013 | 5 | 0.470 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 378 | 0.450 |
Why?
|
| Graft Rejection | 1 | 2018 | 1065 | 0.440 |
Why?
|
| Heparin | 1 | 2013 | 175 | 0.430 |
Why?
|
| Elective Surgical Procedures | 1 | 2013 | 116 | 0.420 |
Why?
|
| Preoperative Care | 1 | 2013 | 397 | 0.380 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2011 | 99 | 0.380 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 104 | 0.370 |
Why?
|
| Robotics | 1 | 2011 | 267 | 0.330 |
Why?
|
| Creatinine | 2 | 2022 | 338 | 0.290 |
Why?
|
| Treatment Outcome | 4 | 2022 | 7993 | 0.290 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2013 | 187 | 0.290 |
Why?
|
| Blood Transfusion | 2 | 2019 | 157 | 0.260 |
Why?
|
| Middle Aged | 11 | 2021 | 25028 | 0.240 |
Why?
|
| Morphine Derivatives | 1 | 2022 | 8 | 0.220 |
Why?
|
| Heart Arrest, Induced | 1 | 2022 | 31 | 0.220 |
Why?
|
| Portal Vein | 1 | 2022 | 120 | 0.210 |
Why?
|
| Length of Stay | 2 | 2018 | 702 | 0.210 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 6509 | 0.210 |
Why?
|
| Injections, Spinal | 1 | 2021 | 44 | 0.210 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2012 | 166 | 0.210 |
Why?
|
| Aged | 7 | 2021 | 18415 | 0.210 |
Why?
|
| Aorta | 1 | 2022 | 280 | 0.200 |
Why?
|
| Pulmonary Edema | 1 | 2021 | 50 | 0.190 |
Why?
|
| Myxoma | 1 | 2020 | 28 | 0.190 |
Why?
|
| Embolism | 1 | 2020 | 31 | 0.190 |
Why?
|
| Arachnodactyly | 1 | 2020 | 2 | 0.190 |
Why?
|
| Stroke Volume | 1 | 2022 | 456 | 0.180 |
Why?
|
| DiGeorge Syndrome | 1 | 2020 | 14 | 0.180 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 29 | 0.180 |
Why?
|
| Female | 9 | 2021 | 44532 | 0.180 |
Why?
|
| Prospective Studies | 3 | 2022 | 4213 | 0.180 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 62 | 0.180 |
Why?
|
| Biomarkers | 2 | 2019 | 1718 | 0.180 |
Why?
|
| Health Status Disparities | 1 | 2022 | 170 | 0.180 |
Why?
|
| Retrospective Studies | 2 | 2024 | 8489 | 0.180 |
Why?
|
| Craniosynostoses | 1 | 2020 | 77 | 0.170 |
Why?
|
| Male | 12 | 2021 | 40965 | 0.170 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2018 | 17 | 0.170 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1823 | 0.170 |
Why?
|
| Glycation End Products, Advanced | 1 | 2018 | 13 | 0.170 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2018 | 20 | 0.170 |
Why?
|
| Risk Factors | 3 | 2022 | 5417 | 0.160 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 190 | 0.160 |
Why?
|
| Electroencephalography | 1 | 2022 | 709 | 0.160 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2018 | 42 | 0.150 |
Why?
|
| Echocardiography | 1 | 2022 | 911 | 0.150 |
Why?
|
| Spleen | 1 | 2018 | 430 | 0.150 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2018 | 78 | 0.150 |
Why?
|
| Heart Failure, Diastolic | 1 | 2016 | 2 | 0.150 |
Why?
|
| Electric Stimulation | 1 | 2018 | 347 | 0.150 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 351 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 187 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 2018 | 181 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2018 | 263 | 0.140 |
Why?
|
| Ventricular Function, Left | 2 | 2018 | 592 | 0.140 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 567 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2018 | 290 | 0.130 |
Why?
|
| Perioperative Care | 1 | 2016 | 161 | 0.130 |
Why?
|
| Septal Occluder Device | 1 | 2013 | 42 | 0.120 |
Why?
|
| Hypoxia | 1 | 2018 | 641 | 0.120 |
Why?
|
| Inflammation | 1 | 2019 | 920 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2018 | 760 | 0.110 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2013 | 130 | 0.110 |
Why?
|
| Respiration, Artificial | 2 | 2011 | 334 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 231 | 0.100 |
Why?
|
| Cysteine | 1 | 2012 | 135 | 0.100 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 56 | 0.100 |
Why?
|
| Organometallic Compounds | 1 | 2012 | 132 | 0.100 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 97 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 364 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 114 | 0.100 |
Why?
|
| Coronary Vessels | 1 | 2012 | 177 | 0.090 |
Why?
|
| Aortic Valve Stenosis | 1 | 2011 | 131 | 0.090 |
Why?
|
| Adult | 4 | 2013 | 25648 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2012 | 377 | 0.090 |
Why?
|
| Hospital Mortality | 1 | 2011 | 349 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2012 | 447 | 0.090 |
Why?
|
| Acute Disease | 1 | 2011 | 826 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 2011 | 355 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2011 | 373 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2011 | 710 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2018 | 3241 | 0.080 |
Why?
|
| Logistic Models | 1 | 2011 | 1186 | 0.080 |
Why?
|
| Hypertension | 1 | 2016 | 1141 | 0.080 |
Why?
|
| Chicago | 1 | 2011 | 1379 | 0.070 |
Why?
|
| Insulin | 1 | 2012 | 1160 | 0.070 |
Why?
|
| Mice | 1 | 2018 | 11352 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2011 | 2261 | 0.060 |
Why?
|
| Pregnancy | 1 | 2011 | 2894 | 0.060 |
Why?
|
| Time Factors | 1 | 2011 | 5210 | 0.060 |
Why?
|
| Stroke | 1 | 2011 | 965 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1373 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2022 | 80 | 0.050 |
Why?
|
| Young Adult | 1 | 2013 | 5976 | 0.050 |
Why?
|
| Animals | 1 | 2018 | 26582 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 165 | 0.040 |
Why?
|
| Heart Atria | 1 | 2020 | 250 | 0.040 |
Why?
|
| Counterpulsation | 1 | 2018 | 21 | 0.040 |
Why?
|
| Reoperation | 1 | 2020 | 597 | 0.040 |
Why?
|
| Vitrectomy | 1 | 2016 | 52 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2022 | 2767 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2013 | 119 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 187 | 0.030 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2013 | 112 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 71 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2012 | 86 | 0.030 |
Why?
|
| Cardiology | 1 | 2013 | 123 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2011 | 30 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 2011 | 17 | 0.030 |
Why?
|
| Cardioplegic Solutions | 1 | 2011 | 17 | 0.030 |
Why?
|
| Ischemia | 1 | 2013 | 243 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2012 | 128 | 0.030 |
Why?
|
| Anesthesiology | 1 | 2013 | 157 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2013 | 240 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 256 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2011 | 148 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2012 | 232 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 318 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2011 | 221 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2012 | 478 | 0.020 |
Why?
|
| Anesthesia | 1 | 2011 | 164 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1673 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 683 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 370 | 0.020 |
Why?
|